SARS-CoV-2 Spike Protein-Mediated Cardiac Dysfunction: Structural Abnormalities, Impaired Calcium Dynamics, and Gene Expression Changes in Human Stem Cell-Derived Cardiomyocytes
- PMID: 41493418
- DOI: 10.1002/jmv.70789
SARS-CoV-2 Spike Protein-Mediated Cardiac Dysfunction: Structural Abnormalities, Impaired Calcium Dynamics, and Gene Expression Changes in Human Stem Cell-Derived Cardiomyocytes
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, has resulted in more than 7.1 million deaths worldwide since 2019 and is increasingly recognized for its cardiovascular complications beyond respiratory disease. Growing evidence suggests that the SARS-CoV-2 spike protein itself, present during infection or after vaccination, may directly contribute to cardiac dysfunction, including myocarditis, through interaction with angiotensin-converting enzyme 2 (ACE2) receptors expressed in cardiomyocytes. To investigate these effects, we established a lentiviral-based SARS-CoV-2 pseudovirus system expressing spike proteins from the Wuhan and Delta variants and examined their impact on human embryonic stem cell-derived cardiomyocytes (ESC-CMs). Exposure to pseudovirus resulted in significant increases in sarcomere length and promoted syncytium formation in ESC-CMs. Moreover, infection with either Wuhan or Delta spike pseudoviruses caused marked early disturbances in intracellular calcium transient dynamics as early as 1.5 hours post-infection, with partial recovery observed by 24 hours. Transcriptomic analyses further revealed significant dysregulation of key cardiac-related genes involved in cell junction organization, structural integrity, ion channel function, and calcium handling. Together, these findings demonstrate the utility of a lentiviral pseudovirus platform for modeling SARS-CoV-2-induced cardiac injury and highlight a direct pathogenic role of the spike protein in cardiac structural, functional, and molecular abnormalities.
Keywords: COVID‐19; SARS‐CoV‐2; calcium transient; cardiac dysfunction; pseudovirus; spike protein.
© 2026 Wiley Periodicals LLC.
References
-
- M. S. Sofi, A. Hamid, and S. U. Bhat, “SARS‐CoV‐2: A Critical Review of Its History, Pathogenesis, Transmission, Diagnosis and Treatment,” Biosafety and Health 2, no. 4 (2020): 217–225.
-
- K. K. Chan, D. Dorosky, P. Sharma, et al., “Engineering Human ACE2 to Optimize Binding to the Spike Protein of SARS Coronavirus 2,” Science 369, no. 6508 (2020): 1261–1265.
-
- W. Tai, L. He, X. Zhang, et al., “Characterization of the Receptor‐Binding Domain (RBD) of 2019 Novel Coronavirus: Implication for Development of RBD Protein as a Viral Attachment Inhibitor and Vaccine,” Cellular & Molecular Immunology 17, no. 6 (2020): 613–620.
-
- R. Amraei, C. Xia, J. Olejnik, et al., “Extracellular Vimentin Is an Attachment Factor That Facilitates SARS‐CoV‐2 Entry Into Human Endothelial Cells,” Proceedings of the National Academy of Sciences 119, no. 6 (2022): e2113874119.
-
- N. Rahimi, “C‐Type Lectin CD209L/L‐SIGN and CD209/DC‐SIGN: Cell Adhesion Molecules Turned to Pathogen Recognition Receptors,” Biology (Basel) 10, no. 1 (2020): 1.
MeSH terms
Substances
Grants and funding
- 114-2321-B-006-012/National Science and Technology Council, R.O.C
- 113-2321-B-006-007/National Science and Technology Council, R.O.C
- 113-2321-B-006-012/National Science and Technology Council, R.O.C
- 113-2320-B-006-047/National Science and Technology Council, R.O.C
- IV-113-PP-11/National Health Research Institutes
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
